Format

Send to

Choose Destination
Immunotherapy. 2018 Feb;10(2):77-80. doi: 10.2217/imt-2017-0144.

Immunotherapy in relapsed mesothelioma.

Author information

1
Thoracic Oncology Department & Early Trial Clinical Research Center, Hospital Bichat-Claude Bernard, Assistance Publique-Hôpitaux de Paris (AP-HP), F-75018 Paris, France.
2
University Paris-Diderot, Paris, France.
3
Pulmonary & Thoracic Oncology, Univ Lille, CHU Lille, INSERM U1019, CIIL, Institut Pasteur de Lille, F59000 Lille, France.
4
French National Network of Clinical Expert Centers for Malignant Pleural Mesothelioma Management (MESOCLIN), Lille, France.
5
U830 Inserm, 'Genetics & Biology of Cancers', Research Center-Institut Curie.
PMID:
29260624
DOI:
10.2217/imt-2017-0144
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center